Microvascular Disease Exercise Trial

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 21, 2020

Study Completion Date

May 17, 2021

Conditions
Coronary Microvascular Disease
Interventions
BEHAVIORAL

Exercise Program

Subject will be exercising on a treadmill 3x/week. Subjects progress will dictate increases/decreases in time of exercise and pace.

Trial Locations (2)

22901

University of Virginia, Charlottesville

22902

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

Astellas Pharma Global Development, Inc.

INDUSTRY

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Virginia

OTHER

NCT02045459 - Microvascular Disease Exercise Trial | Biotech Hunter | Biotech Hunter